干细胞之家 - 中国干细胞行业门户第一站

 

 

搜索
中源协和

免疫细胞治疗专区

欢迎关注干细胞微信公众号

  
查看: 11813|回复: 1
go

求文献。。。关于fibronectin,有点多 [复制链接]

Rank: 2

积分
298 
威望
298  
包包
188  

优秀会员

楼主
发表于 2014-3-26 11:51 |只看该作者 |倒序浏览 |打印
1.Fibronectin expression in glioblastomas promotes cell cohesion, collective invasion of basement membrane in vitro and orthotopic tumor growth in mice, Q: ^$ h& V5 n; @
http://www.nature.com/onc/journa ... pdf/onc2013305a.pdf
; A7 ^! c4 ?9 `2 G2.β1- and αv-class integrins cooperate to regulate myosin II during rigidity sensing of fibronectin-based microenvironments
. s% @9 }. C  @( l/ H, Phttp://www.nature.com/ncb/journal/v15/n6/full/ncb2747.html
& _. i4 M+ ~: y# a3.Epithelial to Mesenchymal Transition Promotes Breast Cancer Progression via a Fibronectin-dependent STAT3 Signaling Pathway8 b% R" B) ~" Y, @( h
http://www.jbc.org/content/288/25/17954.full.pdf+html4 x* a9 ?3 ]0 L; X
4.Mammary epithelial cell interactions with fibronectin stimulate epithelial-mesenchymal transition
' j! R1 C+ n9 d; X8 Ehttp://www.nature.com/onc/journa ... 1dda993f28dc7dacf9c  r, J5 Y  ?9 m
5.Integrin αvβ3 and Fibronectin Upregulate Slug in Cancer Cells to Promote Clot Invasion and Metastasis6 G$ n' A& L$ M) @/ Q
http://cancerres.aacrjournals.or ... /6175.full.pdf+html
9 L5 ], y. J6 Z# c2 J9 [, e6.Nuclear factor of activated T cells mediates RhoA-induced fibronectin upregulation in glomerular podocytes% f5 R& i* G% R% f/ b
http://ajprenal.physiology.org/c ... .full-text.pdf+html
# F6 G" g" g- x7.Overexpression of fibronectin confers cell adhesion‑mediated drug resistance (CAM-DR) against 5-FU in oral squamous cell carcinoma cells7 V+ Q; e1 I: a  S/ @; w  J
http://www.spandidos-publication ... .2265?text=abstract( R5 N$ \* d" h# l% I" o

1 J* y) a6 T8 J" i- ^

Rank: 2

积分
183 
威望
183  
包包
881  
沙发
发表于 2014-3-28 11:52 |只看该作者
是很多
附件: 你需要登录才可以下载或查看附件。没有帐号?注册
已有 1 人评分包包 收起 理由
细胞海洋 + 15 欢迎参与文献互助

总评分: 包包 + 15   查看全部评分

‹ 上一主题|下一主题
你需要登录后才可以回帖 登录 | 注册
验证问答 换一个

Archiver|干细胞之家 ( 吉ICP备2021004615号-3 )

GMT+8, 2026-3-7 17:12

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.